Multiomic

multi-omics, AI, precision medicine

discoverydiscovering

multiomic.health·London, United Kingdom·

01Overview 02People 03Projects 04Concepts 05Patents 06Public records 07Belief evolution

Plate C · C-YYVQ

Summary · Eternal Search editorial

Multiomic multi-omics, AI, precision medicine

Multiomic Health has built a platform for discovering and developing precision medicines for age-related chronic multifactorial diseases. Its initial focus is cardio-renal-metabolic disease, with a first platform use case in chronic kidney disease. The company uses deep longitudinal patient datasets, AI-enabled data science, experimental biology, multiple omics modalities, and longitudinal clinical phenotyping to identify patient subpopulations and develop therapeutics with companion diagnostics.

The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →

Plate C·01 · Scientific profile

All 16 dimensions
on the record.

Composite9

Chain scale100 pts

Dimensions16

Plate C·02 · Where it sits among peers

Score vs. proximity
to longevity goals.

Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.

Reading

Multiomic — Far from goals · Bottom quartile. Derived deterministically from 3 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (2 programs at undisclosed).…

Source: Deterministic

At a glance

Webmultiomic.health

HQLondon, United Kingdom

Publications

13 on file

012026Organic amendments as a tool to restore soil microbial diversity after wildfires in native Mediterranean forests.Journal of environmental management→022026Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy.Science (New York, N.Y.)→032026Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to Chemoradiotherapy.Research square→042025Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network.Cell death and differentiation→052025CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment.Cancer immunology research→062024Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities.American journal of obstetrics and gynecology→072024Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network.bioRxiv : the preprint server for biology→082024Liver-specific mitochondrial amidoxime-reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse models.Hepatology communications→092024Targeting immune-fibroblast cell communication in heart failure.Nature→102021An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease.Nature communications→112021FIREWORKS: a bottom-up approach to integrative coessentiality network analysis.Life science alliance→122020Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities.Cancer discovery→132006Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat.Journal of proteome research→

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence

Multiomic

All 16 dimensionson the record.

Score vs. proximityto longevity goals.

Publications

Loading

All 16 dimensionson the record.

Score vs. proximityto longevity goals.

Publications

All 16 dimensions
on the record.

Score vs. proximity
to longevity goals.

All 16 dimensions
on the record.

Score vs. proximity
to longevity goals.